Drugs / ENTONOX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02230007 | Sep 2013 → Feb 2015 | — | Centre Hospitalier Universitaire de Nice | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ENTONOX | “ENTONOX (MEOPA)gas Duration of treatment of a subject according to the protocol: 60 MINUTES Inhalation use” NCT02230007 ↗ |
| Known as | MEOPA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02230007 ↗ |
| Modality | Other / unclassified | “The gas MEOPA administered to the mask” NCT02230007 ↗ |
| Route | Inhaled | “60 MINUTES Inhalation use” NCT02230007 ↗ |